menu
    • menu
    [{"orgOrder":0,"company":"Palleos Healthcare","sponsor":"F. Hoffmann-La Roche | Phaon Scientific | University Hospital, Essen | University Hospital Erlangen","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"GERMANY","productType":"Antibody","year":"2021","type":"Inapplicable","leadProduct":"Atezolizumab","moa":"Programmed cell death 1 ligand 1","graph1":"Oncology","graph2":"Phase II","graph3":"Palleos Healthcare","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Palleos Healthcare \/ F. Hoffmann-La Roche | Phaon Scientific | University Hospital, Essen | University Hospital Erlangen","highestDevelopmentStatusID":"8","companyTruncated":"Palleos Healthcare \/ F. Hoffmann-La Roche | Phaon Scientific | University Hospital, Essen | University Hospital Erlangen"}]

    Find Clinical Drug Pipeline Developments & Deals by Palleos Healthcare

    Menu

    Palleos Healthcare

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Palleos Healthcare

                            Germany arrow
                            Vitafoods
                            Not Confirmed

                            Palleos Healthcare

                            Germany arrow
                            Vitafoods
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Atezolizumab

                            Therapeutic Area : Oncology

                            Study Phase : Phase II

                            Sponsor : F. Hoffmann-La Roche | Phaon Scientific | University Hospital, Essen | University Hospital Erlangen

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy with Atezolizumab - CTX T...

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Antibody

                            Upfront Cash : Inapplicable

                            February 25, 2021

                            Lead Product(s) : Atezolizumab

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase II

                            Sponsor : F. Hoffmann-La Roche | Phaon Scientific | University Hospital, Essen | University Hospital Erlangen

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Palleos Healthcare

                            Germany arrow
                            Vitafoods
                            Not Confirmed

                            Palleos Healthcare

                            Germany arrow
                            Vitafoods
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Pertuzumab

                            Therapeutic Area : Oncology

                            Study Phase : Phase II

                            Sponsor : F. Hoffmann-La Roche | WSG Women’s Healthcare Study Group | Cankado

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or ...

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Antibody

                            Upfront Cash : Inapplicable

                            September 05, 2017

                            Lead Product(s) : Pertuzumab

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase II

                            Sponsor : F. Hoffmann-La Roche | WSG Women’s Healthcare Study Group | Cankado

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Palleos Healthcare

                            Germany arrow
                            Vitafoods
                            Not Confirmed

                            Palleos Healthcare

                            Germany arrow
                            Vitafoods
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Palbociclib

                            Therapeutic Area : Oncology

                            Study Phase : Phase IV

                            Sponsor : WSG Women’s Healthcare Study Group | Cankado | Pfizer Inc | AGO-TraFo | AGO-B | Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e.V.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and...

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Other Small Molecule

                            Upfront Cash : Inapplicable

                            July 18, 2017

                            Lead Product(s) : Palbociclib

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase IV

                            Sponsor : WSG Women’s Healthcare Study Group | Cankado | Pfizer Inc | AGO-TraFo | AGO-B | Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e.V.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth